1887

Abstract

It was previously shown that two mutant influenza A viruses expressing C-terminally truncated forms of the NS1 protein (NS1-81 and NS1-110) were temperature sensitive . These viruses contain HA, NA and M genes derived from influenza A/WSN/33 H1N1 virus (mouse-adapted), and the remaining five genes from human influenza A/Victoria/3/75 virus. Mice intranasally infected with the NS1 mutant viruses showed undetectable levels of virus in lungs at day 3, whereas those infected with the NS1 wild-type control virus still had detectable levels of virus at this time. Nevertheless, the temperature-sensitive mutant viruses induced specific cellular and humoral immune responses similar to those induced by the wild-type virus. Mice immunized with the NS1 mutant viruses were protected against a lethal challenge with influenza A/WSN/33 virus. These results indicate that truncations in the NS1 protein resulting in temperature-sensitive phenotypes correlate with attenuation without compromising viral immunogenicity, an ideal characteristic for live attenuated viral vaccines.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80991-0
2005-10-01
2020-08-10
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/10/2817.html?itemId=/content/journal/jgv/10.1099/vir.0.80991-0&mimeType=html&fmt=ahah

References

  1. Aragón T., de La Luna S., Novoa I., Carrasco L., Ortín J., Nieto A. 2000; Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol Cell Biol 20:6259–6268 [CrossRef]
    [Google Scholar]
  2. Enami M., Luytjes W., Krystal M., Palese P. 1990; Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci U S A 87:3802–3805 [CrossRef]
    [Google Scholar]
  3. Falcón A. M., Marión R. M., Zürcher T., Gómez P., Portela A., Nieto A., Ortín J. 2004; Defective RNA replication and late gene expression in temperature-sensitive influenza viruses expressing deleted forms of the NS1 protein. J Virol 78:3880–3888 [CrossRef]
    [Google Scholar]
  4. Ferko B., Stasakova J., Sereinig S., Romanova J., Katinger D., Niebler B., Katinger H., Egorov A. 2001; Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice. J Virol 75:8899–8908 [CrossRef]
    [Google Scholar]
  5. Ferko B., Stasakova J., Romanova J., Kittel C., Sereinig S., Katinger H., Egorov A. 2004; Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol 78:13037–13045 [CrossRef]
    [Google Scholar]
  6. Fodor E., Devenish L., Engelhardt O. G., Palese P., Brownlee G. G., García-Sastre A. 1999; Rescue of influenza A virus from recombinant DNA. J Virol 73:9679–9682
    [Google Scholar]
  7. Fortes P., Beloso A., Ortín J. 1994; Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J 13:704–712
    [Google Scholar]
  8. García-Sastre A., Egorov A., Matassov D., Brandt S., Levy D. E., Durbin J. E., Palese P., Muster T. 1998; Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324–330 [CrossRef]
    [Google Scholar]
  9. López C. B., García-Sastre A., Williams B. R. G., Moran T. M. 2003; Type I interferon induction pathway, but not released interferon, participates in the maturation of dendritic cells induced by negative-strand RNA viruses. J Infect Dis 187:1126–1136 [CrossRef]
    [Google Scholar]
  10. Lu Y., Qian X. Y., Krug R. M. 1994; The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev 8:1817–1828 [CrossRef]
    [Google Scholar]
  11. Murata K., García-Sastre A., Tsuji M. 7 other authors 1996; Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol 173:96–107 [CrossRef]
    [Google Scholar]
  12. Neumann G., Watanabe T., Ito H. 9 other authors 1999; Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96:9345–9350 [CrossRef]
    [Google Scholar]
  13. Noah D. L., Twu K. Y., Krug R. M. 2003; Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307:386–395 [CrossRef]
    [Google Scholar]
  14. Palese P., García-Sastre A. 2002; Influenza vaccines: present and future. J Clin Invest 110:9–13 [CrossRef]
    [Google Scholar]
  15. Qiu Y., Krug R. M. 1994; The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). J Virol 68:2425–2432
    [Google Scholar]
  16. Schultz-Cherry S., Dybdahl-Sissoko N., Neumann G., Kawaoka Y., Hinshaw V. S. 2001; Influenza virus NS1 protein induces apoptosis in cultured cells. J Virol 75:7875–7881 [CrossRef]
    [Google Scholar]
  17. Stasakova J., Ferko B., Kittel C., Sereinig S., Romanova J., Katinger H., Egorov A. 2005; Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol 86:185–195 [CrossRef]
    [Google Scholar]
  18. Takasuka N., Enami M., Itamura S., Takemori T. 2002; Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice. Vaccine 20:1579–1585 [CrossRef]
    [Google Scholar]
  19. Talon J., Horvath C. M., Polley R., Basler C. F., Muster T., Palese P., García-Sastre A. 2000a; Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996 [CrossRef]
    [Google Scholar]
  20. Talon J., Salvatore M., O'Neill R. E., Nakaya Y., Zheng H., Muster T., García-Sastre A., Palese P. 2000b; Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci U S A 97:4309–4314 [CrossRef]
    [Google Scholar]
  21. Thompson W. W., Shay D. K., Weintraub E., Brammer L., Cox N., Anderson L. J., Fukuda K. 2003; Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179–186 [CrossRef]
    [Google Scholar]
  22. Webster R. G. 2002; The importance of animal influenza for human disease. Vaccine 20:S16–S20 [CrossRef]
    [Google Scholar]
  23. Zhirnov O. P., Konakova T. E., Wolff T., Klenk H. D. 2002; NS1 protein of influenza A virus down-regulates apoptosis. J Virol 76:1617–1625 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80991-0
Loading
/content/journal/jgv/10.1099/vir.0.80991-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error